Largeaud L, Fregona V, Jamrog L, Hamelle C, Dufrechou S, Prade N
Blood Cancer J. 2025; 15(1):7.
PMID: 39885120
PMC: 11782539.
DOI: 10.1038/s41408-025-01213-z.
Katerndahl C, Rogers O, Day R, Xu Z, Helton N, Ramakrishnan S
Proc Natl Acad Sci U S A. 2024; 121(18):e2317690121.
PMID: 38648485
PMC: 11067031.
DOI: 10.1073/pnas.2317690121.
Katsumura K, Liu P, Kim J, Mehta C, Bresnick E
Proc Natl Acad Sci U S A. 2024; 121(10):e2317147121.
PMID: 38422019
PMC: 10927522.
DOI: 10.1073/pnas.2317147121.
Ren H, Hong M, Feng J, Hao Z, Chen X, Liang F
Biomol Biomed. 2024; 24(4):982-989.
PMID: 38416121
PMC: 11293240.
DOI: 10.17305/bb.2024.10244.
Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N
Int J Mol Sci. 2024; 25(1).
PMID: 38203823
PMC: 10779750.
DOI: 10.3390/ijms25010652.
Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins D, Pavletich T, Patil A, Pahopos D, Lasarev M, Polaki U
Blood Adv. 2023; 8(1):80-92.
PMID: 38029365
PMC: 10787255.
DOI: 10.1182/bloodadvances.2023011554.
Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency.
Soukup A, Bresnick E
Blood Adv. 2023; 7(24):7564-7575.
PMID: 37871305
PMC: 10761364.
DOI: 10.1182/bloodadvances.2023011003.
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Heyes E, Wilhelmson A, Wenzel A, Manhart G, Eder T, Schuster M
Nat Commun. 2023; 14(1):6185.
PMID: 37794021
PMC: 10550934.
DOI: 10.1038/s41467-023-41927-x.
A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.
West R, Bauer T, Tuschong L, Embree L, Calvo K, Tillo D
Blood Adv. 2023; 7(20):6351-6363.
PMID: 37595058
PMC: 10587712.
DOI: 10.1182/bloodadvances.2023010458.
The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency.
Santiago M, Liquori A, Such E, Zuniga A, Cervera J
Cancers (Basel). 2023; 15(5).
PMID: 36900380
PMC: 10000430.
DOI: 10.3390/cancers15051590.
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.
Marin-Bejar O, Romero-Moya D, Rodriguez-Ubreva J, Distefano M, Lessi F, Aretini P
Haematologica. 2023; 108(9):2551-2557.
PMID: 36815365
PMC: 10483368.
DOI: 10.3324/haematol.2022.282305.
Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung M, Shen S, Botten G, Olender T, Katsumura K, Johnson K
J Clin Invest. 2023; 133(7).
PMID: 36809258
PMC: 10065080.
DOI: 10.1172/JCI162685.
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A, Geron I, Kugler E, Fishman H, Gottlieb E, Abramovich I
Haematologica. 2022; 108(9):2316-2330.
PMID: 36475518
PMC: 10483369.
DOI: 10.3324/haematol.2022.279437.
The spectrum of GATA2 deficiency syndrome.
Calvo K, Hickstein D
Blood. 2022; 141(13):1524-1532.
PMID: 36455197
PMC: 10082373.
DOI: 10.1182/blood.2022017764.
GATA 2 Deficiency: Focus on Immune System Impairment.
Fabozzi F, Mastronuzzi A, Ceglie G, Masetti R, Leardini D
Front Immunol. 2022; 13:865773.
PMID: 35769478
PMC: 9234111.
DOI: 10.3389/fimmu.2022.865773.
[Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].
Yao H, Yang X, Zhang X, Wang P, Deng X, Luo M
Zhonghua Xue Ye Xue Za Zhi. 2022; 42(12):1042-1045.
PMID: 35045679
PMC: 8770874.
DOI: 10.3760/cma.j.issn.0253-2727.2021.12.015.
Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts.
Heshusius S, Grech L, Gillemans N, Brouwer R, den Dekker X, van IJcken W
Sci Rep. 2022; 12(1):336.
PMID: 35013432
PMC: 8748495.
DOI: 10.1038/s41598-021-04126-6.
GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program.
Johnson K, Soukup A, Bresnick E
Blood Adv. 2022; 6(5):1464-1473.
PMID: 35008108
PMC: 8905696.
DOI: 10.1182/bloodadvances.2021006182.
Conditionally pathogenic genetic variants of a hematopoietic disease-suppressing enhancer.
Soukup A, Matson D, Liu P, Johnson K, Bresnick E
Sci Adv. 2021; 7(50):eabk3521.
PMID: 34890222
PMC: 8664263.
DOI: 10.1126/sciadv.abk3521.
A Comprehensive Characterization of Monoallelic Expression During Hematopoiesis and Leukemogenesis Single-Cell RNA-Sequencing.
Fu R, Qin P, Zou X, Hu Z, Hong N, Wang Y
Front Cell Dev Biol. 2021; 9:702897.
PMID: 34722498
PMC: 8548578.
DOI: 10.3389/fcell.2021.702897.